Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
NEW YORK (Reuters Health) – Patients on long-term stable warfarin therapy can safely be immunized against influenza, results of study from Italy indicate. In the study, influenza vaccination…
NEW YORK (Reuters Health) – Octogenarians with heart failure have a higher risk of in-hospital death after defibrillator or pacemaker placement, compared to younger patients, new research shows.…
NEW YORK (Reuters Health) – Adding omega-3 polyunsaturated fatty acids (PUFAs) to dual antiplatelet therapy after stent implantation boosts patients’ platelet response, investigators in Poland report. The P2Y12…
NEW YORK (Reuters Health) – Upgrading traditional 2 chamber cardiac pacemakers to modern 3 chamber pacemakers — cardiac resynchronization therapy (CRT) devices — improves left ventricular ejection fraction…
NEW YORK (Reuters Health) – Ambulatory telemetry can provide lifesaving information that is unavailable with other modalities, new research suggests. More than 26,000 patients with routine clinical indications…
NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…
NEW YORK (Reuters Health) – The advantages of primary percutaneous coronary intervention (PCI) over fibrinolysis for patients with ST-segment elevation myocardial infarction (STEMI) are maintained for 8 years,…
NEW YORK (Reuters Health) – Patients starting clozapine must be monitored for endocarditis during the first month, particularly at week 3, new research shows. The researchers also suggest…
NEW YORK (Reuters Health) – To reduce the risk of adverse ischemic outcomes and death, angioplasty should be done within 24 hours of presentation for non-ST-segment elevation acute…
NEW YORK (Reuters Health) – In diabetics with heart failure, use of metformin is associated with a lower risk of mortality than use of other anti-diabetic agents, even…
